The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
(1989) · PubMed · Cited by 3,343
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90047-7 · Cited by 574
Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique
Trotta, M., Debernardi, F., & Caputo, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00135-2 · Cited by 439
Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content
Budhian, A., Siegel, S. J., & Winey, K. I. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.061 · Cited by 431
DATE, A., & NAGARSENKER, M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.038 · Cited by 407
Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery
SHAH, K., DATE, A., JOSHI, M., & PATRAVALE, V (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.061 · Cited by 359
Fundarò, A., Cavalli, R., Bargoni, A., Vighetto, D., Zara, G. P., & Gasco, M. R. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0695 · Cited by 317
LIU, J., GONG, T., WANG, C., ZHONG, Z., & ZHANG, Z. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.009 · Cited by 282
Dreis, S., Rothweiler, F., Michaelis, M., Cinatl, J., Kreuter, J., & Langer, K. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.036 · Cited by 275
Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles
Cavalli, R. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04822-3 · Cited by 273
Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN)
Schwarz, C., & Mehnert, W. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00222-6 · Cited by 234
Barraud, L., Merle, P., Soma, E., Lefrançois, L., Guerret, S., Chevallier, M., Dubernet, C., Couvreur, P., Trépo, C., & Vitvitski, L. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.035 · Cited by 217
Solid lipid nanoparticles (SLN) for controlled drug delivery
Müller, R. H., Freitas, C., zur Mühlen, A., & Mehnert, W. (1996) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)86243-4 · Cited by 174
Serpe, L., Catalano, M. G., Cavalli, R., Ugazio, E., Bosco, O., Canaparo, R., Muntoni, E., Frairia, R., Gasco, M. R., Eandi, M., et al. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.026 · Cited by 165
Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions
Trotta, M., Gallarate, M., Pattarino, F., & Morel, S. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00432-1 · Cited by 152
Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan
Kim, B.-D., Na, K., & Choi, H. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.10.008 · Cited by 137
Self-citationShort- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy
del Pozo‐Rodríguez, A., Solinís, M. Á., Rodríguez‐Gascón, A., & Pedraz, J. L. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.015 · Cited by 129
PHARMACOKINETICS OF DOXORUBICIN INCORPORATED IN SOLID LIPID NANOSPHERES (SLN)
Zara, G. P., Cavalli, R., Fundaro', A., Bargoni, A., Caputo, O., & Gasco, M. R. (1999) · Pharmacological Research · doi:10.1006/phrs.1999.0509 · Cited by 122
Sauvant, C., Nowak, M., Wirth, C., Schneider, B., Riemann, A., Gekle, M., & Thews, O. (2008) · International Journal of Cancer · doi:10.1002/ijc.23818 · Cited by 109
Wong, H. L., Rauth, A. M., Bendayan, R., & Wu, X. Y. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.022 · Cited by 109
Переверзева, Э. Р., Трещалин, И. Д., Бодягин, Д. А., Максименко, О. О., Langer, K., Dreis, S., Asmussen, B., Kreuter, J., & Gelperina, S. E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.01.031 · Cited by 77
Némati, F. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04559-0 · Cited by 75
A study of the freeze-drying conditions of calixarene based solid lipid nanoparticles
Shahgaldian, P. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00196-0 · Cited by 72
Jumaa, M., & Müller, B. W. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00057-7 · Cited by 59
Kanke, M., TANABE, E., KATAYAMA, H., Yoko, K. O. D. A., & YOSHITOMI, H. (1995) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.18.1154 · Cited by 49
Kang, S. I., Na, K., & Bae, Y. H. (2003) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2003.09.006 · Cited by 48
Kanke, M., Koda, K., Koda, Y., & Katayama, H. (1992) · Pharmaceutical Research · doi:10.1023/a:1015811523426 · Cited by 24
Shin, J. N., Seo, Y. W., Kim, M., Park, S., Lee, M., Lee, B. R., Oh, J., Seol, D., & Kim, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413865200 · Cited by 23
Kanke, M., KATAYAMA, H., & NAKAMURA, M. (1995) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.18.1104 · Cited by 22
Cited by
A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems
Duan, Y., Dhar, A., Patel, C., Khimani, M., Neogi, S., Sharma, P., Siva Kumar, N., & Vekariya, R. L. (2020) · RSC Advances · doi:10.1039/d0ra03491f · Cited by 614
Ganesan, P., & Narayanasamy, D. (2017) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2017.07.002 · Cited by 434
Abdelaziz, H. M., Gaber, M., Abd-Elwakil, M. M., Mabrouk, M. T., Elgohary, M. M., Kamel, N. M., Kabary, D. M., Freag, M. S., Samaha, M. W., Mortada, S. M., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.036 · Cited by 409
Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance
Creixell, M., & Peppas, N. A. (2012) · Nano Today · doi:10.1016/j.nantod.2012.06.013 · Cited by 331
Intravesical drug delivery: Challenges, current status, opportunities and novel strategies
GuhaSarkar, S., & Banerjee, R. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.031 · Cited by 285
Metadata
- Authors
- Subedi, R. K., Kang, K. W., & Choi, H.-K.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 37
- Issue
- 3-4
- Pages
- 508-513
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2109624279
- Cited by
- 301
- References
- 34
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.